Home › Funds › ACORN CAPITAL ADVISORS, LLC › KPTI
ACORN CAPITAL ADVISORS, LLC position in KPTI
KARYOPHARM THERAPEUTICS INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 1,222,019 shares of KPTI (KARYOPHARM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.41% of its reported portfolio and ranking #19 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed KPTI holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's KPTI position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in KPTI in Q1 2026 at 287,826 shares (US$1.6M). The position peaked in Q2 2026 at 1,518,113 shares, worth US$14.8M. Across 3 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,222,019 shares valued at US$1.5M — a reduction of -296,094 shares quarter over quarter.. Notable position changes include a 427% increase in Q2 2026 (shares fell 88% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 287.83K | $1.60M | New |
| Q2 2026 | 1.52M | $14.83M | Add |
| Q3 2026 | 1.22M | $1.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KPTI and 13F data
KPTI (KARYOPHARM THERAPEUTICS INC) is a Health Care company. 18 other funds we track also report a position in KPTI — the largest reported positions include Catalio Capital Management, LP (US$9.2M), Avidity Partners Management LP (US$9.0M), NEA Management Company, LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KPTI
- Catalio Capital Management, LP 940.86K sh · $9.19M · Q2 2026
- Avidity Partners Management LP 924.49K sh · $9.03M · Q2 2026
- NEA Management Company, LLC 576.78K sh · $5.64M · Q2 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held KPTI?
ACORN CAPITAL ADVISORS, LLC has disclosed KPTI holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is ACORN CAPITAL ADVISORS, LLC's current position in KPTI?
As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 1.22M shares of KPTI (KARYOPHARM THERAPEUTICS INC), valued at $1.49M, representing 0.41% of its reported portfolio and ranking #19.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling KPTI?
In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC reduced its position in KPTI. The position peaked in Q2 2026 at 1.52M shares.
Which other funds hold KPTI?
Other major institutional holders of KPTI include Catalio Capital Management, LP, Avidity Partners Management LP, NEA Management Company, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.